News

2019

company

year

domain

Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota Transplantationse

Seres Therapeutics 06.19.2019

FDA Grants Fast Track Designation for Torque’s First Deep-Primed T Cell Cancer Immunotherapy Program, TRQ-1501

06.18.2019

Indigo Launches the Terraton Initiative™ to Remove One Trillion Tons of Carbon Dioxide from the Atmosphere

Indigo Agriculture 06.12.2019

Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs

06.05.2019

Quanterix Raises $49.7 Million and Announces Introduction of Latest Model Simoa HD-X Analyzer at BIO 2019 International Convention

Quanterix 06.04.2019

TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage

TransMedics 06.03.2019

Sigilon Therapeutics Hires Glenn Reicin, Veteran Banking and Finance Strategist, as CFO

Sigilon Therapeutics 06.03.2019

Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Meeting

Moderna 06.01.2019

Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board

05.29.2019

Quanterix Expands Headquarters to New, State-Of-The-Art Facility in Billerica, Mass. As Demand Continues to Grow for Its Disruptive Simoa Platforms

Quanterix 05.29.2019

Loading